Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Liabilities (2016 - 2025)

Historic Total Liabilities for AC Immune (ACIU) over the last 12 years, with Q3 2025 value amounting to $136.5 million.

  • AC Immune's Total Liabilities rose 363.5% to $136.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.5 million, marking a year-over-year increase of 363.5%. This contributed to the annual value of $135.4 million for FY2024, which is 44185.19% up from last year.
  • As of Q3 2025, AC Immune's Total Liabilities stood at $136.5 million, which was up 363.5% from $139.5 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Total Liabilities ranged from a high of $139.5 million in Q2 2025 and a low of $22721.8 during Q1 2021
  • Moreover, its 5-year median value for Total Liabilities was $23.2 million (2022), whereas its average is $53.1 million.
  • Per our database at Business Quant, AC Immune's Total Liabilities crashed by 9990.29% in 2021 and then skyrocketed by 10182475.83% in 2022.
  • AC Immune's Total Liabilities (Quarter) stood at $32.0 million in 2021, then tumbled by 44.95% to $17.6 million in 2022, then soared by 42.08% to $25.0 million in 2023, then surged by 441.85% to $135.4 million in 2024, then increased by 0.76% to $136.5 million in 2025.
  • Its Total Liabilities stands at $136.5 million for Q3 2025, versus $139.5 million for Q2 2025 and $129.3 million for Q1 2025.